Last week we concluded our master’s edition 2017-2018. After nine months of hard work, board of professors, students and managing directors of the Biotechnology Business Institute joined together the presentation of the final projects in the framework of the first year of the educational agreement Discover & Transfer.

The new educational model, presented by the Institute, is based on real intellectual property projects and drug candidates, which makes possible a new way of learning focused on practical aspects. The collaboration agreements with the Biomedical Research Institute of Barcelona (IRB Barcelona) and the Fundació Bosch i Gimpera (FBG), both international reference research centers in Barcelona had allowed our students to work with current investigations of the institutions and follow up their discoveries in real plans.

The final thesis defense involved the whole work of the students since they started last October working on the feasibility plans, and the researchers and innovation managers didn’t want to miss the presentations.

Throughout the academic course, there had been different meetings between the students and the researchers to follow up together the different stages of the business plans, drug developments plans and brand plans from the different specializations. In addition, an expert jury, integrated by a group of professionals from the sector, where responsible of its evaluation and final remarks.

Finally, that evening, as part of their graduation, the students took part during the Summer Charity Cocktail. As part of its commitment with innovation and entrepreneurship, the Biotechnology Business Institute and Richi Entrepreneurs presented the first Childhood Cancer Innovation Award, a charity event in favor of pediatric investigation.

Latest news

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Barcelona has been the first city hosting ENABLE symposium, an European initiative for young scientists included in the “Celebrating European Science” section of the EU’s Horizon 2020 Program

 More than 300 PhD and Postdoctoral students from all over Europe have met in the first European symposium of Biomedicine held in the Palauet Casades, in the centre of Barcelona. The conference, entitled "Breaking down complexity. Innovative models and techniques in Biomedicine" connected the students with new career opportunities in the world of science unexplored for most researchers.

The Biotechnology Business Institute inaugurated the fifth edition of the master’s programs with the consolidation of its innovative educational model, Discover&Transfer

After the success of the first edition of the Discover&Transfer program, the new students of the Biotechnology Business Institute will develop new patents from the main research institutions of Barcelona.

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

Filter by category